New liposomal drug shows promise in early solid tumor trial
NCT ID NCT03207672
First seen Feb 25, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This early-phase study tests a new drug called E7389 liposomal formulation in people with advanced solid tumors that have not responded to standard treatments. The main goal is to find the safest dose and check for side effects. The study includes people with several cancer types, including breast cancer, and aims to see if the drug can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eisai Trial Site 1
Chuo-ku, Tokyo, Japan
-
Eisai Trial Site 10
Hidaka, Saitama, Japan
-
Eisai Trial Site 11
Kyoto, Japan
-
Eisai Trial Site 12
Fukuoka, Japan
-
Eisai Trial Site 2
Osaka, Japan
-
Eisai Trial Site 3
Kashiwa, Chiba, Japan
-
Eisai Trial Site 4
Koto-ku, Tokyo, Japan
-
Eisai Trial Site 5
Sapporo, Hokkaido, Japan
-
Eisai Trial Site 6
Yokohama, Kanagawa, Japan
-
Eisai Trial Site 7
Shinjuku-ku, Tokyo, Japan
-
Eisai Trial Site 8
Nishinomiya, Hyōgo, Japan
-
Eisai Trial Site 9
Bunkyo-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.